Cargando…
Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder
Background and Objectives: Aripiprazole is a first-line agent in the treatment of bipolar disorder (BD) and available data demonstrates its efficacy on clinical symptoms in serotonin reuptake inhibitors-resistant obsessive-compulsive disorder (OCD) patients. Therefore, aripiprazole augmentation to m...
Autores principales: | Di Salvo, Gabriele, Maina, Giuseppe, Pessina, Enrico, Teobaldi, Elena, Barbaro, Francesca, Martini, Azzurra, Albert, Umberto, Rosso, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824272/ https://www.ncbi.nlm.nih.gov/pubmed/33374357 http://dx.doi.org/10.3390/medicina57010009 |
Ejemplares similares
-
Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder
por: Amerio, Andrea, et al.
Publicado: (2018) -
Aripiprazole augmentation in managing comorbid obsessive–compulsive disorder and bipolar disorder: a case with suicidal attempts
por: Lai, Jianbo, et al.
Publicado: (2016) -
Aripiprazole-induced obsessive–compulsive symptoms
por: Nafisa, Dilshana, et al.
Publicado: (2022) -
Aripiprazole Augmentation in Patients with Resistant Obsessive Compulsive Disorder: a Pilot Study
por: Delle Chiaie, Roberto, et al.
Publicado: (2011) -
Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report
por: Fornaro, Michele, et al.
Publicado: (2008)